TABLE 1.
Characteristic | Characteristic Subgroup | No. | %b |
---|---|---|---|
Total | 11 302 | 100 | |
Sex | Male | 6 153 | 54.4 |
Female | 5 149 | 45.6 | |
Age (years) | 0–4 | 3 687 | 32.6 |
5–9 | 2 818 | 24.9 | |
10–14 | 2 560 | 22.7 | |
15–19 | 2 237 | 19.8 | |
Race/ethnicity | White, non-Hispanic | 7 506 | 66.4 |
Black, non-Hispanic | 1 378 | 12.2 | |
Hispanic | 1 951 | 17.3 | |
Other, non-Hispanic | 467 | 4.1 | |
US census region | Northeast | 2 545 | 22.5 |
Midwest | 2 495 | 22.1 | |
South | 3 332 | 29.5 | |
West | 2 930 | 25.9 | |
Economic status by countyc | Bottom 25% | 1 457 | 12.9 |
25–75% | 6 723 | 59.5 | |
Top 25% | 2 806 | 24.8 | |
Stage | Localized | 8 273 | 73.2 |
Regional | 1 371 | 12.1 | |
Distant | 808 | 7.1 | |
Unknown | 850 | 7.5 | |
Anatomic site | Lobe | 2 348 | 20.8 |
Cerebrum | 915 | 8.1 | |
Ventricle | 642 | 5.7 | |
Cerebellum | 2 956 | 26.2 | |
Brainstem | 1 438 | 12.7 | |
Other brain | 2 083 | 18.4 | |
Other CNS | 920 | 8.1 | |
Histologyd | Pilocytic astrocytoma | 3 480 | 30.8 |
Diffuse astrocytoma | 1 196 | 10.6 | |
Anaplastic astrocytoma | 355 | 3.1 | |
Unique astrocytoma variants | 213 | 1.9 | |
Glioblastoma | 541 | 4.8 | |
Oligodendroglioma | 281 | 2.5 | |
Anaplastic oligodendroglioma | 52 | 0.5 | |
Oligoastrocytic tumors | 173 | 1.5 | |
Ependymal tumors | 988 | 8.7 | |
Glioma malignant, not otherwise specified | 548 | 4.8 | |
Choroid plexus tumors | 105 | 0.9 | |
Neuronal and mixed neuronal glial tumors | 97 | 0.9 | |
Medulloblastoma | 1 680 | 14.9 | |
Peripheral neuroectodermal tumor | 558 | 4.9 | |
Atypical teratoid/rhabdoid tumor | 288 | 2.5 | |
Other embryonal tumors | 227 | 2.0 | |
Tumors of meninges | 114 | 1.0 | |
Germ cell tumors and cysts | 307 | 2.7 | |
Unclassified tumors | 69 | 0.6 |
Data were compiled from 34 population-based registries that participate in the Centers for Disease Control and Prevention’s National Program of Cancer Registries, and meet high-quality data criteria. The registries in the Survival Analysis Dataset cover approximately 67% of the US population. For more information, see US Cancer Statistics technical notes (http://www.cdc.gov/cancer/npcr/uscs/technical_notes/stat_methods/survival.htm).
Percentage is calculated with the denominator of 11,302.
Excludes 316 missing cases.
Excludes histology categories with <16 cases.
CNS, central nervous system.